Template:Butalbital/aspirin/caffeine: Difference between revisions
Jump to navigation
Jump to search
(Created page with "{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; ! style="padding: 0 5px; font-size: 100%; background:#F8F8...") |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; | {| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; | ||
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Butalbital/aspirin/caffeine | ! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Butalbital/aspirin/caffeine|{{fontcolor|#6C7B8B|Butalbital/aspirin/caffeine}}]]''''' | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | | ! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS bultabital, aspirin and caffeine tablet <sup>®</sup> FDA Package Insert | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS (bultabital, aspirin and caffeine tablets) tablet indications and usage|Indications and Usage]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS (bultabital, aspirin and caffeine tablets) tablet dosage and administration|Dosage and Administration]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS (bultabital, aspirin and caffeine tablets) tablet dosage forms and strengths|Dosage Forms and Strengths]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS (bultabital, aspirin and caffeine tablets) tablet contraindications|Contraindications]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS (bultabital, aspirin and caffeine tablets) tablet warnings and precautions|Warnings and Precautions]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS (bultabital, aspirin and caffeine tablets) tablet adverse reactions|Adverse Reactions]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS (bultabital, aspirin and caffeine tablets) tablet drug interactions|Drug Interactions]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS (bultabital, aspirin and caffeine tablets) tablet use in specific populations|Use in Specific Populations]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS (bultabital, aspirin and caffeine tablets) tablet overdosage|Overdosage]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS (bultabital, aspirin and caffeine tablets) tablet description|Description]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS (bultabital, aspirin and caffeine tablets) tablet clinical pharmacology|Clinical Pharmacology]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS (bultabital, aspirin and caffeine tablets) tablet nonclinical toxicology|Nonclinical Toxicology]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS (bultabital, aspirin and caffeine tablets) tablet clinical studies|Clinical Studies]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS (bultabital, aspirin and caffeine tablets) tablet how supplied storage and handling|How Supplied/Storage and Handling]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS (bultabital, aspirin and caffeine tablets) tablet patient counseling information|Patient Counseling Information]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS (bultabital, aspirin and caffeine tablets) tablet labels and packages|Labels and Packages]] | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on Butalbital/aspirin/caffeine | |||
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on | |||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} ClinicalTrials.gov] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} ClinicalTrials.gov] | ||
|- | |- | ||
|} | |} |
Latest revision as of 04:08, 12 February 2014
Butalbital/aspirin/caffeine |
---|
BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS bultabital, aspirin and caffeine tablet ® FDA Package Insert |
Indications and Usage |
Dosage and Administration |
Dosage Forms and Strengths |
Contraindications |
Warnings and Precautions |
Adverse Reactions |
Drug Interactions |
Use in Specific Populations |
Overdosage |
Description |
Clinical Pharmacology |
Nonclinical Toxicology |
Clinical Studies |
How Supplied/Storage and Handling |
Patient Counseling Information |
Labels and Packages |
Clinical Trials on Butalbital/aspirin/caffeine |
ClinicalTrials.gov |